Nordea Investment Management Ab Regeneron Pharmaceuticals, Inc. Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 34,532 shares of REGN stock, worth $24.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

34,532

Previous 45,261 23.7%

Holding current value

$24.7 Million

Previous $47.6 Million 23.69%

% of portfolio

0.04%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$1024.09 - $1201.76 $11 Million - $12.9 Million	-10,729 Reduced 23.7%	34,532 $36.3 Million
Q2 2024 Aug 08, 2024	BUY	$883.2 - $1071.19 $14.2 Million - $17.2 Million	16,066 Added 55.03%	45,261 $47.6 Million
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $4.96 Million - $5.46 Million	5,495 Added 23.19%	29,195 $28.1 Million
Q4 2023 Jan 10, 2024	SELL	$775.18 - $881.7 $67,440 - $76,707	-87 Reduced 0.37%	23,700 $20.8 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $944,501 - $1.15 Million	-1,364 Reduced 5.42%	23,787 $19.6 Million
Q2 2023 Jul 07, 2023	SELL	$700.03 - $830.35 $293,312 - $347,916	-419 Reduced 1.64%	25,151 $18.1 Million
Q1 2023 Apr 19, 2023	BUY	$680.49 - $826.97 $237,491 - $288,612	349 Added 1.38%	25,570 $21 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $680,477 - $738,799	-964 Reduced 3.68%	25,221 $18.2 Million
Q3 2022 Oct 19, 2022	SELL	$573.97 - $724.32 $3.56 Million - $4.49 Million	-6,194 Reduced 19.13%	26,185 $18.2 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $9.04 Million - $12.2 Million	-16,491 Reduced 33.74%	32,379 $19 Million
Q1 2022 Apr 11, 2022	SELL	$595.12 - $698.43 $1.31 Million - $1.54 Million	-2,206 Reduced 4.32%	48,870 $34.4 Million
Q4 2021 Jan 20, 2022	SELL	$543.48 - $670.97 $525,545 - $648,827	-967 Reduced 1.86%	51,076 $32.8 Million
Q3 2021 Nov 01, 2021	SELL	$574.03 - $680.96 $29.9 Million - $35.4 Million	-52,043 Reduced 50.0%	52,043 $31.9 Million
Q3 2021 Nov 01, 2021	BUY	$574.03 - $680.96 $30.6 Million - $36.2 Million	53,233 Added 104.68%	104,086 $63 Million
Q2 2021 Jul 16, 2021	BUY	$472.8 - $558.54 $221,743 - $261,955	469 Added 0.93%	50,853 $28.4 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $1.01 Million - $1.24 Million	2,270 Added 4.72%	50,384 $23.8 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $2.19 Million - $2.78 Million	4,573 Added 10.5%	48,114 $23.2 Million
Q3 2020 Nov 09, 2020	SELL	$544.75 - $658.21 $198,833 - $240,246	-365 Reduced 0.83%	43,541 $25 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $14 Million - $18.2 Million	28,313 Added 181.58%	43,906 $27.4 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $34,962 - $51,420	-104 Reduced 0.66%	15,593 $7.25 Million
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $15,625 - $21,461	57 Added 0.36%	15,697 $5.89 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $24,611 - $28,655	90 Added 0.58%	15,640 $4.31 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $648,334 - $897,670	2,164 Added 16.17%	15,550 $4.87 Million
Q1 2019 May 20, 2019	BUY	$372.08 - $439.57 $3.41 Million - $4.03 Million	9,171 Added 217.58%	13,386 $5.49 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $22,472 - $26,144	64 Added 1.54%	4,215 $1.7 Million
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $5.9 Million - $7.15 Million	-20,720 Reduced 83.31%	4,151 $1.43 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $240,023 - $299,272	-760 Reduced 2.97%	24,871 $8.57 Million
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $1.02 Million - $1.33 Million	-2,839 Reduced 9.97%	25,631 $9.64 Million
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $12.3 Million - $14.3 Million	28,470	28,470 $12.7 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Regeneron Pharmaceuticals, Inc. Transaction History